BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30511145)

  • 1. Efficacy and prognostic factors of transarterial embolization as initial treatment for spontaneously ruptured hepatocellular carcinoma: a single-center retrospective analysis in 57 patients.
    Zhou C; Zu QQ; Wang B; Zhou CG; Shi HB; Liu S
    Jpn J Radiol; 2019 Mar; 37(3):255-263. PubMed ID: 30511145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization.
    Jin YJ; Lee JW; Park SW; Lee JI; Lee DH; Kim YS; Cho SG; Jeon YS; Lee KY; Ahn SI
    World J Gastroenterol; 2013 Jul; 19(28):4537-44. PubMed ID: 23901230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and Prognostic Factors in Patients with Spontaneously Ruptured Hepatocellular Carcinoma.
    Matsumoto T; Chung H; Suginoshita Y; Ito K; Inokuma T
    Hepatogastroenterology; 2015 Jun; 62(140):942-6. PubMed ID: 26902033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients.
    Zhou C; Zu QQ; Liu XL; Wang B; Zhou CG; Shi HB; Liu S
    Diagn Interv Radiol; 2020 May; 26(3):223-229. PubMed ID: 32209506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study.
    Kirikoshi H; Saito S; Yoneda M; Fujita K; Mawatari H; Uchiyama T; Higurashi T; Imajo K; Sakaguchi T; Atsukawa K; Sawabe A; Kanesaki A; Takahashi H; Abe Y; Inamori M; Kobayashi N; Kubota K; Ueno N; Nakajima A
    BMC Gastroenterol; 2009 Apr; 9():29. PubMed ID: 19405938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization.
    Jundt MC; Owen RL; Thompson SM; Fleming CJ; Stockland AH; Andrews JC
    Abdom Radiol (NY); 2022 Jan; 47(1):416-422. PubMed ID: 34633495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effect of polyvinyl alcohol particles combined with chemoembolization in treatment of hepatocellular carcinoma complicated by hepatic arteriovenous shunt and related and prognostic factors].
    Liu QS; Mei QL; Li YH; He XF; Zeng QL; Pang HJ; Xiao LJ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):834-839. PubMed ID: 27978929
    [No Abstract]   [Full Text] [Related]  

  • 13. Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child-Pugh C Cirrhosis?
    Fan WZ; Zhang YQ; Yao W; Wang Y; Tan GS; Huang YH; Yang JY; Li JP
    J Vasc Interv Radiol; 2018 Mar; 29(3):404-412.e3. PubMed ID: 29249595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.
    Zhu Q; Li J; Yan JJ; Huang L; Wu MC; Yan YQ
    World J Gastroenterol; 2012 Dec; 18(48):7302-7. PubMed ID: 23326137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience.
    Liu CL; Fan ST; Lo CM; Tso WK; Poon RT; Lam CM; Wong J
    J Clin Oncol; 2001 Sep; 19(17):3725-32. PubMed ID: 11533094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
    Liu QS; Mei QL; Li YH
    Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma.
    Li WH; Cheuk EC; Kowk PC; Cheung MT
    J Hepatobiliary Pancreat Surg; 2009; 16(4):508-12. PubMed ID: 19381430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.